drugset / Trial / NCT03298347

Caffeine for Preterm Infants With Apnea of Prematurity(AOP)

NCT03298347

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Nowadays,caffein is commonly used for AOP, and it reduces the intubation rate in preterm infants. However, intubation is needed in about 20%-50% of partial neonates. How to reduce the intubation rate effectively is a challenge for neonatologists.

Timeline

Start
2017-10-01
Primary completion
2018-10-01
Completion
2018-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 20 mg/kg
Subject Caffeine Small molecule 80 mg/kg

Indications